Abstract
Schizophrenic psychoses represent the main indication for psychopharmacotherapy. Foremost among the drugs with antipsychotic effects are the neuroleptics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alanen YO, Räkköläinen V, Laakso J (1982) Krankheitsmodelle bei der Schizophrenie und die Bedürfnisangemessenheit der Behandlung. Nervenarzt 53: 150–153
Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA (1984) Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Psychiatr Scand 69: 49–74
Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatr Res 3: 115–122
Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacologie treatment of psychoses. Arch Gen Psychiatry 45: 79–91
Benedetti G (1987) Wahn und Halluzination in psychiatrischer Sicht. In: Olbrich HM (ed) Halluzination und Wahn. Springer, Berlin Heidelberg New York
Bigelow LB, Kirch DG, Braun T, Korpi ED, Wagner RL, Zalcman S, Wyatt RJ (1985) Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study. Psychopharmacol Bull 21: 66–68
Campbell M, Grega DM, Green WH, Bennet WG (1983) Neuroleptic-induced dyskinesias in children. Clin Neuropharmacol 6: 207–222
Cohen BM (1988) Neuroleptic drugs in the treatment of acute psychoses: how much do we really know? Psychopharmacol Ser 5: 47–61
Crow TJ (1980) Molecular pathology of schizophrenia: more than one dimension of pathology? Br Med J 280: 66–68
Dalery J, Maillet J, de Villard R (1985) Traitment de dix-sept adolescents psychotiques par le dogmatil. Sem Hôp Paris 61: 1327–1330
Davis JM, Schaffer CB, Kilian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6: 70–87
Denber HCB, Bente D, Rajotte P (1962) Comparative analysis of the action of butyrylperazine at Manhattan State Hospital and the University Psychiatric Clinic at Erlangen. Am J Psychiatry 119: 203–206
Eggers C (1973) Verlaufsweisen kindlicher und präpuberaler Schizophrenien. Springer, Berlin Heidelberg New York
Eggers C (1975) Nichtdelirante Intoxikationspsychosen im Kindesalter. Z Kinderheilkd 119: 71–86
Eggers C (1984) Rezeptorverhalten der Psychopharmaka. In: Nissen G, Eggers C, Martinius J Kinder- und jugendpsychiatrische Pharmakotherapie in Klinik und Praxis. Springer, Berlin Heidelberg New York, pp 15–29
Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71–76
Gerlach J, Behnke K, Heltberg J, Munk-Andersen E, Nilsen H (1985) Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effects, side effects and plasma concentrations. Br J Psychiatry 147: 283–288
Gualtieri CT, Barnhill J, McGimsey J, Schell D (1980) Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs. J Am Acad Child Psychiatry 19: 491–510
Marder SR, van Putten T, Mintz J, McKenzie J, Lebell M, Faltico G, May PRA (1984) Costs and benefits of two doses of fluphenazine. Arch Gen Psychiatry 41: 1025–1029
Marder SR, van Putten T, Mintz J (1987) Low and conventional dose maintenance therapy with fluphenazine decanoate: two year outcome. Arch Gen Psychiatry 44: 518–521
Mc Andrew JB, Case Q, Treffert DA (1972) Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. J Autism Child Schizophr 2: 75–91
Müller WE (1989) Neuroleptika. Die Dopamin-Hypothese im neuen Gewand. Dtsch Apoth Z 129: 799–806
Polizos R, Engelhardt DM (1978) Dyskinetic phenomena in children treated with psychotropic medications. Psychopharmacol Bull 14: 65–68
Sedvall G, Farde L, Persson A, Wiesel FA (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43: 995–1005
Uschakov GK (1965) Clinique de la schizophrénie. Psychiatr Enfant 8: 1–48
Waddington JL (1989) Sight and insight: brain dopamine receptor occupancy by neuroleptics visualised in living schizophrenic patients by positron emission tomography. Br J Psychiatry 154: 433–436
Woggon B (1987) Dosierung von Neuroleptika. In: Pichot P, Möller HJ (eds) Tropon Symposium, vol. 2. Springer, Berlin Heidelberg New York, pp 81–91
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Eggers, C., Röpke, B. (1991). Pharmacotherapy of Schizophrenia in Childhood and Adolescence. In: Eggers, C. (eds) Schizophrenia and Youth. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02684-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-02684-7_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52485-4
Online ISBN: 978-3-662-02684-7
eBook Packages: Springer Book Archive